[{"address1": "1560 Trapelo Road", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 786 8230", "fax": "781 786 8866", "website": "https://www.dyne-tx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 192, "companyOfficers": [{"maxAge": 1, "name": "Mr. John G. Cox M.B.A.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 1028185, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Oxana  Beskrovnaya Ph.D.", "age": 63, "title": "Chief Innovation Officer", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 719521, "exercisedValue": 2172731, "unexercisedValue": 3736735}, {"maxAge": 1, "name": "Ms. Johanna  Friedl-Naderer", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 748769, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Douglas  Kerr M.B.A., M.D., Ph.D.", "age": 56, "title": "Chief Medical Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 745640, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rajesh  Manchanda Ph.D.", "age": 57, "title": "Chief Technical Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James P. Bilotta M.B.A.", "title": "Chief Digital & Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Wilson", "age": 52, "title": "Senior VP & Head of Legal", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lucia  Celona", "age": 58, "title": "Chief Human Resource Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Feldman", "age": 53, "title": "Chief Regulatory Affairs Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ashish  Dugar M.B.A., Ph.D.", "title": "Chief Medical Affairs Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.74, "open": 11.77, "dayLow": 11.56, "dayHigh": 12.09, "regularMarketPreviousClose": 11.74, "regularMarketOpen": 11.77, "regularMarketDayLow": 11.56, "regularMarketDayHigh": 12.09, "payoutRatio": 0.0, "beta": 1.189, "forwardPE": -3.7436707, "volume": 2156044, "regularMarketVolume": 2156044, "averageVolume": 2461000, "averageVolume10days": 3657160, "averageDailyVolume10Day": 3657160, "bid": 8.57, "ask": 15.0, "bidSize": 2, "askSize": 2, "marketCap": 1344680576, "fiftyTwoWeekLow": 6.36, "fiftyTwoWeekHigh": 47.45, "fiftyDayAverage": 10.6353, "twoHundredDayAverage": 24.050076, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 690513600, "profitMargins": 0.0, "floatShares": 97508874, "sharesOutstanding": 113667000, "sharesShort": 14859045, "sharesShortPriorMonth": 11341719, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.1308, "heldPercentInsiders": 0.0069, "heldPercentInstitutions": 1.10831, "shortRatio": 5.12, "shortPercentOfFloat": 0.1504, "impliedSharesOutstanding": 113667000, "bookValue": 5.887, "priceToBook": 2.0095124, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -367129984, "trailingEps": -3.61, "forwardEps": -3.16, "enterpriseToEbitda": -1.747, "52WeekChange": -0.66817415, "SandP52WeekChange": 0.11469197, "quoteType": "EQUITY", "currentPrice": 11.83, "targetHighPrice": 66.0, "targetLowPrice": 14.0, "targetMeanPrice": 46.64286, "targetMedianPrice": 50.0, "recommendationMean": 1.57143, "recommendationKey": "buy", "numberOfAnalystOpinions": 14, "totalCash": 677491968, "totalCashPerShare": 5.96, "ebitda": -395312000, "totalDebt": 23330000, "quickRatio": 19.996, "currentRatio": 20.35, "debtToEquity": 3.487, "returnOnAssets": -0.39922002, "returnOnEquity": -0.64014, "freeCashflow": -176840128, "operatingCashflow": -319724992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "DYN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Dyne Therapeutics, Inc.", "longName": "Dyne Therapeutics, Inc.", "regularMarketChangePercent": 0.7666112, "regularMarketPrice": 11.83, "postMarketTime": 1747435751, "regularMarketTime": 1747425601, "marketState": "CLOSED", "corporateActions": [], "exchange": "NMS", "messageBoardId": "finmb_608699906", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 0.09000015, "regularMarketDayRange": "11.56 - 12.09", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2461000, "fiftyTwoWeekLowChange": 5.47, "fiftyTwoWeekLowChangePercent": 0.86006284, "fiftyTwoWeekRange": "6.36 - 47.45", "fiftyTwoWeekHighChange": -35.620003, "fiftyTwoWeekHighChangePercent": -0.750685, "fiftyTwoWeekChangePercent": -66.81741, "earningsTimestamp": 1746703800, "earningsTimestampStart": 1754909940, "earningsTimestampEnd": 1755259200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.61, "epsForward": -3.16, "epsCurrentYear": -3.88968, "priceEpsCurrentYear": -3.0413814, "fiftyDayAverageChange": 1.1947002, "fiftyDayAverageChangePercent": 0.112333484, "twoHundredDayAverageChange": -12.220076, "twoHundredDayAverageChangePercent": -0.5081096, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-17", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1600349400000, "postMarketChangePercent": -0.676246, "postMarketPrice": 11.75, "postMarketChange": -0.0799999, "displayName": "Dyne Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]